|
1
|
La Torre G, Kirch W, Bes-Rastrollo M,
Ramos RM, Czaplicki M, Gualano MR, Thümmler K, Ricciardi W and
Boccia A; GHPSS, ; Collaborative Group, : Tobacco use among medical
students in Europe: Results of a multicentre study using the Global
Health Professions Student Survey. Public Health. 126:159–164.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arantes LM, de Carvalho AC, Melendez ME,
Carvalho AL and Goloni-Bertollo EM: Methylation as a biomarker for
head and neck cancer. Oral Oncol. 50:587–592. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kumar B, Cordell KG, Lee JS, Worden FP,
Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, et al:
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as
indicators of response to therapy and survival in oropharyngeal
cancer. J Clin Oncol. 26:3128–3137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kolk A, Wermker K, Bier H, Götz C and
Eckert AW: Current surgical and adjuvant therapy concepts of
malignant tumors of the facial skin and the pinna.
Laryngorhinootologie. 94:77–85. 2015.(In German). PubMed/NCBI
|
|
5
|
Fakhry C, Sugar E, D'Souza G and Gillison
M: Two-week versus six-month sampling interval in a short-term
natural history study of oral HPV infection in an HIV-positive
cohort. PLoS One. 5:e119182010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bagan JV and Scully C: Recent advances in
Oral Oncology 2007: Epidemiology, aetiopathogenesis, diagnosis and
prognostication. Oral Oncol. 44:103–108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lindenblatt RC, Martinez GL, Silva LE,
Faria PS, Camisasca DR and Lourenço SQ: Oral squamous cell
carcinoma grading systems - analysis of the best survival
predictor. J Oral Pathol Med. 41:34–39. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mücke T, Koschinski J, Wolff KD, Kanatas
A, Mitchell DA, Loeffelbein DJ, Deppe H and Rau A: Quality of life
after different oncologic interventions in head and neck cancer
patients. J Craniomaxillofac Surg. 43:1895–1898. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
González-García R, Naval-Gías L,
Román-Romero L, Sastre-Pérez J and Rodríguez-Campo FJ: Local
recurrences and second primary tumors from squamous cell carcinoma
of the oral cavity: A retrospective analytic study of 500 patients.
Head Neck. 31:1168–1180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park MJ, Roh JL, Kim SB, Choi SH, Nam SY
and Kim SY: Prognostic value of circulating biomarker score in
advanced-stage head and neck squamous cell carcinoma. Eur J Cancer.
92:69–76. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thomas SM, Bhola NE, Zhang Q, Contrucci
SC, Wentzel AL, Freilino ML, Gooding WE, Siegfried JM, Chan DC and
Grandis JR: Cross-talk between G protein-coupled receptor and
epidermal growth factor receptor signaling pathways contributes to
growth and invasion of head and neck squamous cell carcinoma.
Cancer Res. 66:11831–11839. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kalyankrishna S and Grandis JR: Epidermal
growth factor receptor biology in head and neck cancer. J Clin
Oncol. 24:2666–2672. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fouad YA and Aanei C: Revisiting the
hallmarks of cancer. Am J Cancer Res. 7:1016–1036. 2017.PubMed/NCBI
|
|
14
|
Magee JA, Piskounova E and Morrison SJ:
Cancer stem cells: Impact, heterogeneity, and uncertainty. Cancer
Cell. 21:283–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nguyen LV, Vanner R, Dirks P and Eaves CJ:
Cancer stem cells: An evolving concept. Nat Rev Cancer. 12:133–143.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Knudsen ES, Dervishaj O, Kleer CG, Pajak
T, Schwartz GF and Witkiewicz AK: EZH2 and ALDH1 expression in
ductal carcinoma in situ: Complex association with recurrence and
progression to invasive breast cancer. Cell Cycle. 12:2042–2050.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schäfer A, Teufel J, Ringel F, Bettstetter
M, Hoepner I, Rasper M, Gempt J, Koeritzer J, Schmidt-Graf F, Meyer
B, et al: Aldehyde dehydrogenase 1A1 - a new mediator of resistance
to temozolomide in glioblastoma. Neuro-oncol. 14:1452–1464. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reid P, Wilson P, Li Y, Marcu LG,
Staudacher AH, Brown MP and Bezak E: In vitro investigation of head
and neck cancer stem cell proportions and their changes following
X-ray irradiation as a function of HPV status. PLoS One.
12:e01861862017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Campos MS, Neiva KG, Meyers KA,
Krishnamurthy S and Nör JE: Endothelial derived factors inhibit
anoikis of head and neck cancer stem cells. Oral Oncol. 48:26–32.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qian X, Wagner S, Ma C, Klussmann JP,
Hummel M, Kaufmann AM and Albers AE: ALDH1-positive cancer
stem-like cells are enriched in nodal metastases of oropharyngeal
squamous cell carcinoma independent of HPV status. Oncol Rep.
29:1777–1784. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sritippho T, Pongsiriwet S,
Lertprasertsuke N, Buddhachat K, Sastraruji T and Iamaroon A: p16 -
a Possible Surrogate Marker for High-Risk Human Papillomaviruses in
Oral Cancer? Asian Pac J Cancer Prev. 17:4049–4057. 2016.PubMed/NCBI
|
|
24
|
Hoesli R, Birkeland AC, Rosko AJ, Issa M,
Chow KL, Michmerhuizen NL, Mann JE, Chinn SB, Shuman AG, Prince ME,
et al: Proportion of CD4 and CD8 tumor infiltrating lymphocytes
predicts survival in persistent/recurrent laryngeal squamous cell
carcinoma. Oral Oncol. 77:83–89. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Alipoor FJ, Asadi MH and Torkzadeh-Mahani
M: MIAT lncRNA is overexpressed in breast cancer and its inhibition
triggers senescence and G1 arrest in MCF7 cell line. J Cell
Biochem. 18–Jan;2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao P, Hu YC and Talbot IC: Expressing
patterns of p16 and CDK4 correlated to prognosis in colorectal
carcinoma. World J Gastroenterol. 9:2202–2206. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Milanovic M, Fan DNY, Belenki D, Däbritz
JHM, Zhao Z, Yu Y, Dörr JR, Dimitrova L, Lenze D, Monteiro Barbosa
IA, et al: Senescence-associated reprogramming promotes cancer
stemness. Nature. 553:96–100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Okuma A, Hanyu A, Watanabe S and Hara E:
p16Ink4a and p21Cip1/Waf1 promote tumour growth by
enhancing myeloid-derived suppressor cells chemotaxis. Nat Commun.
8:20502017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wolff KD, Follmann M and Nast A: The
diagnosis and treatment of oral cavity cancer. Dtsch Arztebl Int.
109:829–835. 2012.PubMed/NCBI
|
|
30
|
Götz C, Drecoll E, Straub M, Bissinger O,
Wolff KD and Kolk A: Impact of HPV infection on oral squamous cell
carcinoma. Oncotarget. 7:76704–76712. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bissinger O, Kolk A, Drecoll E, Straub M,
Lutz C, Wolff KD and Götz C: EGFR and Cortactin: Markers for
potential double target therapy in oral squamous cell carcinoma.
Exp Ther Med. 14:4620–4626. 2017.PubMed/NCBI
|
|
32
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.PubMed/NCBI
|
|
33
|
La Porta CA, Zapperi S and Sethna JP:
Senescent cells in growing tumors: Population dynamics and cancer
stem cells. PLOS Comput Biol. 8:e10023162012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Solomon I, Voiculescu VM, Caruntu C, Lupu
M, Popa A, Ilie MA, Albulescu R, Caruntu A, Tanase C, Constantin C,
et al: Neuroendocrine Factors and Head and Neck Squamous Cell
Carcinoma: An Affair to Remember. Dis Markers. 2018:97878312018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Burke HB: Outcome prediction and the
future of the TNM staging system. J Natl Cancer Inst. 96:1408–1409.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Magni M, Shammah S, Schiró R, Mellado W,
Dalla-Favera R and Gianni AM: Induction of
cyclophosphamide-resistance by aldehyde-dehydrogenase gene
transfer. Blood. 87:1097–1103. 1996.PubMed/NCBI
|
|
39
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Boxberg M, Jesinghaus M, Dorfner C, Mogler
C, Drecoll E, Warth A, Steiger K, Bollwein C, Meyer P, Wolff KD, et
al: Tumour budding activity and cell nest size determine patient
outcome in oral squamous cell carcinoma: Proposal for an adjusted
grading system. Histopathology. 70:1125–1137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu J, Mu Q, Thiviyanathan V, Annapragada A
and Vigneswaran N: Cancer stem cells are enriched in Fanconi anemia
head and neck squamous cell carcinomas. Int J Oncol. 45:2365–2372.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ikawa M, Impraim CC, Wang G and Yoshida A:
Isolation and characterization of aldehyde dehydrogenase isozymes
from usual and atypical human livers. J Biol Chem. 258:6282–6287.
1983.PubMed/NCBI
|
|
43
|
Resetkova E, Reis-Filho JS, Jain RK, Mehta
R, Thorat MA, Nakshatri H and Badve S: Prognostic impact of ALDH1
in breast cancer: A story of stem cells and tumor microenvironment.
Breast Cancer Res Treat. 123:97–108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Clay MR, Tabor M, Owen JH, Carey TE,
Bradford CR, Wolf GT, Wicha MS and Prince ME: Single-marker
identification of head and neck squamous cell carcinoma cancer stem
cells with aldehyde dehydrogenase. Head Neck. 32:1195–1201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu J, Müller S, Nannapaneni S, Pan L, Wang
Y, Peng X, Wang D, Tighiouart M, Chen Z, Saba NF, et al: Comparison
of quantum dot technology with conventional immunohistochemistry in
examining aldehyde dehydrogenase 1A1 as a potential biomarker for
lymph node metastasis of head and neck cancer. Eur J Cancer.
48:1682–1691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
He KF, Zhang L, Huang CF, Ma SR, Wang YF,
Wang WM, Zhao ZL, Liu B, Zhao YF, Zhang WF, et al: CD163+
tumor-associated macrophages correlated with poor prognosis and
cancer stem cells in oral squamous cell carcinoma. BioMed Res Int.
2014:8386322014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rasper M, Schäfer A, Piontek G, Teufel J,
Brockhoff G, Ringel F, Heindl S, Zimmer C and Schlegel J: Aldehyde
dehydrogenase 1 positive glioblastoma cells show brain tumor stem
cell capacity. Neuro-oncol. 12:1024–1033. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bednarz-Knoll N, Nastały P, Żaczek A,
Stoupiec MG, Riethdorf S, Wikman H, Müller V, Skokowski J, Szade J,
Sejda A, et al: Stromal expression of ALDH1 in human breast
carcinomas indicates reduced tumor progression. Oncotarget.
6:26789–26803. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Morimoto K, Kim SJ, Tanei T, Shimazu K,
Tanji Y, Taguchi T, Tamaki Y, Terada N and Noguchi S: Stem cell
marker aldehyde dehydrogenase 1-positive breast cancers are
characterized by negative estrogen receptor, positive human
epidermal growth factor receptor type 2, and high Ki67 expression.
Cancer Sci. 100:1062–1068. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Alamgeer M, Ganju V, Kumar B, Fox J, Hart
S, White M, Harris M, Stuckey J, Prodanovic Z, Schneider-Kolsky ME,
et al: Changes in aldehyde dehydrogenase-1 expression during
neoadjuvant chemotherapy predict outcome in locally advanced breast
cancer. Breast Cancer Res. 16:R442014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sharpless NE: INK4a/ARF: A multifunctional
tumor suppressor locus. Mutat Res. 576:22–38. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Emig R, Magener A, Ehemann V, Meyer A,
Stilgenbauer F, Volkmann M, Wallwiener D and Sinn HP: Aberrant
cytoplasmic expression of the p16 protein in breast cancer is
associated with accelerated tumour proliferation. Br J Cancer.
78:1661–1668. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chen YW, Chu HC, Ze-Shiang Lin, Shiah WJ,
Chou CP, Klimstra DS and Lewis BC: p16 Stimulates CDC42-dependent
migration of hepatocellular carcinoma cells. PLoS One.
8:e693892013. View Article : Google Scholar : PubMed/NCBI
|
